You know that and we might know that but the investment world does not know that.
Why didn't the company make a strategic decision to have the Cides tested in a Chimp or overseas for humanitaruan use,... long ago?
Even now they can do it if they wanted to. I would say a humanitarian use project somewhere in the world would do more for the technoolgy's advancement than anything done to date by the company during the last 3 years.
The company is strong on science, strong on producing test results, srtong on fine tuning the cides,..etc.
The weakness is in advancing the technology towards a final product. Granted there is huge opposition to such a new technology. But there are countries where because of the human suffering, they could care less for those things. If a solution presents itself, they go for it.
If Eva or someone in Africa (where we are supposed to have some connections) were to help us set up some humanitarian tests and IF they were successful, the stock would propel to the $10 area easliy The company would need to get the proper PR people on board to insure the word gets out,.. that other countries fighting similar diseases hear about it.
The company could then issue a ton load of shares at these higher prices and we would be hme free to moving this technology to a final product.
We could then approah all the other countries that are in need and afterwards the USA would be knocking at OUR door when they see thoses smaller countries having solved HIV, Dengue, Flu, Pink-Eye, etc.
We would probably be able to set up big pharma deals very easliy along the way.
Yes I know you have all sorts of reasons why the company has not or will not do this.
But we are still a couple of years away from doing a clinical trial here. I have been here for over six years and if I would have said to you six years ago, that in six years there will STILL be no clinical trials done and that not even for another year or two,..so 7-8 years before clinical trial since we discovered NNVC.
Yet we had working drugs (on mice) YEARS ago. What about all the lives they could have saved around the world if they would have gone the humanitarian route?
Why not go both routes,... one might enhance the other.
Market Data 
Markets 
AI
